Empirical study of the compensation mechanism with the drug addition policy canceled at municipal public hospitals of Anshan city
10.3760/cma.j.issn.1000-6672.2014.09.002
- VernacularTitle:鞍山市公立医院取消药品加成政策后补偿机制的实证研究
- Author:
Fang WU
;
Feng GUO
;
Qincheng HE
- Publication Type:Journal Article
- Keywords:
Public hospital;
Drug addition;
Compensation mechanism
- From:
Chinese Journal of Hospital Administration
2014;(9):645-650
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the feasibility of various compensation approaches and their combination after canceling the drug addition at municipal public hospitals in Anshan city.Methods 2008~201 1 medical services,balance of payments of Anshan municipal public hospitals during 2008~201 1 were analyzed,to calculate the balance of profit and loss of the hospitals with the drug addition canceled,as well as the effects of various compensation models and their combinations on hospitals’balance,government financial burden,costs of health insurance and patients’out-of-packet costs.Results Without drug addition,hospitals are found with surplus drop,and doubled number of years in deficit.Losses incurred by the canceling can be covered partly by pricing adjustment of medical services or collection of pharmaceutical service surcharge,with complete compensation by collection of medical service surcharge;government financial subsidies for large equipment depreciation or medical services offer part of the compensation,which is affordable by government finance.Such deficits cannot be covered completely by any single approach,yet they can be greatly eased by a combination of the approaches mentioned above.With impacts on all stakeholders in consideration,the optimal solution is the combination of the scheme with adjusted services price plus collection of pharmaceutical service surcharge and medical services compensation.Conclusion With the drug addition policy canceled,the establishment and perfection of the compensation mechanism calls for a synergy of pricing,health insurance and government finance.
